GlassScriptPhysician profile
Edward C Grendys
NPI 1669479747
$340,543.85
in general payments reported to CMS, 2019-2025
34 companies · $12K in 2025
The $12K reported for 2025 was more than what 91% of Gynecologic Oncology providers received nationally (typical 2025 total: $305).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $131K · 2020: $35K · 2021: $33K · 2022: $49K · 2023: $45K · 2024: $37K · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $55K · Consulting Fee: $22K · Travel and Lodging: $7,220 · Education: $5,540 · Food and Beverage: $3,728.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $55,146.00 |
| Consulting Fee | $21,769.60 |
| Travel and Lodging | $7,220.15 |
| Education | $5,540.15 |
| Food and Beverage | $3,727.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $147,596.16 | 2019-2025 | Lynparza |
| Glaxosmithkline, LLC. | $55,159.37 | 2019-2025 | Jemperli, Zejula |
| Tesaro, INC. | $48,706.11 | 2019 | |
| Merck Sharp & Dohme LLC | $19,383.13 | 2019-2025 | Keytruda, Lynparza, Lenvima |
| Immunogen, INC. | $17,040.12 | 2023 | Elahere |
| Clovis Oncology, INC. | $12,821.72 | 2019-2022 | |
| Abbvie INC. | $8,956.26 | 2019-2025 | |
| Stryker Corporation | $8,511.85 | 2019-2022 | |
| Eisai INC. | $6,262.49 | 2020-2025 | |
| Intuitive Surgical, INC. | $5,949.24 | 2019-2024 | |
| Pfizer INC. | $3,852.69 | 2024-2025 | |
| Baxter Healthcare | $3,392.20 | 2021-2025 | Tisseel, Adept, Seprafilm |
| Medical Device Business Services, INC. | $1,050.00 | 2020 | |
| Ethicon US, LLC | $371.67 | 2021-2022 | |
| Ethicon INC. | $350.00 | 2021 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seagen INC. | $288.13 | 2021-2025 | Tivdak |
| Myriad Genetic Laboratories, INC. | $282.91 | 2021-2025 | Precisetumor, Myrisk |
| Foundation Medicine, INC. | $109.32 | 2019 | |
| Medtronic, INC. | $104.86 | 2022-2023 | Linq II |
| Momentis Surgical INC. | $92.00 | 2022 | |
| Fennec Pharmaceuticals, INC. | $49.32 | 2024-2025 | Fyarro, Pedmark |
| Distalmotion US | $25.80 | 2025 | Dexter L6 Robot |
| Verastem, INC. | $24.23 | 2025 | Avmapki Fakzynja Co-Pack |
| Karl Storz Endoscopy-America | $21.96 | 2025 | |
| Kci USA, INC. | $21.91 | 2020 | |
| Novartis Pharmaceuticals Corporation | $19.78 | 2023 | |
| Caris Mpi, INC. | $19.61 | 2025 | Mi Cancer Seek |
| Solventum Corporation | $15.22 | 2024 | Prevena |
| Hologic Sales and Service, LLC | $15.16 | 2020 | |
| Tempus Ai, INC | $14.47 | 2024 | |
| Teleflex LLC | $13.97 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $11.47 | 2019 | |
| Meditrina | $10.72 | 2025 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Grendys listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.